Alpheus Medical
PrivateLast Round
Series B
Jul 30, 2026
Total Funding Raised
$82M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Alpheus Medical is a biotechnology company developing a sonodynamic therapy (SDT) platform that pairs a tumor-accumulating drug with low-intensity ultrasound to treat solid body cancers.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alpheus Medical Comparables
Compare Alpheus Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| QV Bioelectronics | 80% | |
| Hemerion Therapeutics | 78% | |
| SonALAsense | 78% |
Alpheus Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 30, 2026 | ||||
| Series B | May 15, 2025 | ||||
| Series A Extension | Nov 10, 2022 | ||||
| Series A | Nov 17, 2021 |
Alpheus Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Action Potential Venture Capital | Series A Extension, Series B, Series A |
| OrbiMed | Series A Extension, Series B, Series A |
| The Sontag Foundation | Series B |
| BrightEdge | Series A, Series A Extension, Series B |
| Samsara BioCapital | Series B |
| HealthQuest Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 30, 2026
$60M round completed.
- May 17, 2026
Monthly visitors increased 83% MoM.
Recent news
Latest coverage and updates
- is_developingOct 8, 2026
Alpheus Medical Inc. develops Porphyrin Metabolite Activation (PoMA(TM) therapy through a new clinical trial in Minnesota on Oct 8th '26
Alpheus Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Alpheus Medical's valuation, stock price, and market status.
Is Alpheus Medical a public or private company?
Alpheus Medical is a private company.
What is the current stock price of Alpheus Medical?
Alpheus Medical is a private company, so its shares have no public market price. Caplight tracks Alpheus Medical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Alpheus Medical worth (valuation)?
Valuation information for Alpheus Medical is not publicly available.
Can I buy Alpheus Medical stock?
Alpheus Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Alpheus Medical's last funding round?
Alpheus Medical's most recent funding round was Series B on July 30, 2026.
Who are the main investors in Alpheus Medical?
Key investors in Alpheus Medical include Action Potential Venture Capital, OrbiMed, Samsara BioCapital, HealthQuest Capital.
Will Alpheus Medical IPO soon?
No public IPO plans have been announced for Alpheus Medical.
How can I track Alpheus Medical secondary market activity?
Caplight tracks bids, offers, and trades in Alpheus Medical's shares on secondary markets.